BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12021103)

  • 21. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
    Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
    Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GAD65 as a prototypic autoantigen.
    Fenalti G; Rowley MJ
    J Autoimmun; 2008 Nov; 31(3):228-32. PubMed ID: 18514483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. The Childhood Diabetes in Finland Study Group.
    Söhnlein P; Müller M; Syren K; Hartmann U; Böhm BO; Meinck HM; Knip M; Akerblom HK; Richter W
    Diabetologia; 2000 Feb; 43(2):210-7. PubMed ID: 10753043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase.
    Richter W; Shi Y; Baekkeskov S
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2832-6. PubMed ID: 7681990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
    Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
    Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of enzyme activity and antigenicity after mutagenesis of the membrane anchoring domain of GAD65.
    Plesner A; Hampe CS; Daniels TL; Hammerle LP; Lernmark A
    Autoimmunity; 2001; 34(4):221-30. PubMed ID: 11905848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of human monoclonal autoantibodies to glutamic acid decarboxylase.
    Hayakawa N; Premawardhana LD; Powell M; Masuda M; Arnold C; Sanders J; Evans M; Chen S; Jaume JC; Baekkeskov S; Smith BR; Furmaniak J
    Autoimmunity; 2002 Aug; 35(5):343-55. PubMed ID: 12515289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of continuous B-cell epitopes in the N-terminus of glutamate decarboxylase67 using monoclonal antibodies.
    Agca S; Houen G; Trier NH
    J Pept Sci; 2014 Dec; 20(12):928-34. PubMed ID: 25358241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of an autoreactive conformational epitope on GAD65 recognised by the human monoclonal antibody b78 using a combination of phage display, in vitro mutagenesis and molecular modelling.
    O'Connor KH; Banga JP; Darmanin C; El-Kabbani O; Mackay IR; Rowley MJ
    J Autoimmun; 2006 May; 26(3):172-81. PubMed ID: 16564157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformation-dependent GAD65 autoantibodies in diabetes.
    Luo D; Gilliam LK; Greenbaum C; Bekris L; Hampe CS; Daniels T; Richter W; Marcovina SM; Rolandsson O; Landin-Olsson M; Kockum I; Lernmark A
    Diabetologia; 2004 Sep; 47(9):1581-91. PubMed ID: 15365614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between antibodies to the MR 67,000 isoform of glutamate decarboxylase (GAD) and type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune polyendocrine syndrome type II.
    Seissler J; Bieg S; Yassin N; Mauch L; Northemann W; Boehm BO; Scherbaum WA
    Autoimmunity; 1994; 19(4):231-8. PubMed ID: 7578849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes.
    Daw K; Powers AC
    Diabetes; 1995 Feb; 44(2):216-20. PubMed ID: 7532143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies against GAD65 rather than GAD67 precede the onset of type 1 diabetes.
    Lühder F; Schlosser M; Mauch L; Haubruck H; Rjasanowski I; Michaelis D; Kohnert KD; Ziegler M
    Autoimmunity; 1994; 19(2):71-80. PubMed ID: 7772705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.
    Reijonen H; Daniels TL; Lernmark A; Nepom GT
    Diabetes; 2000 Oct; 49(10):1621-6. PubMed ID: 11016444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase.
    Hagopian WA; Michelsen B; Karlsen AE; Larsen F; Moody A; Grubin CE; Rowe R; Petersen J; McEvoy R; Lernmark A
    Diabetes; 1993 Apr; 42(4):631-6. PubMed ID: 8454115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects.
    Schloot NC; Roep BO; Wegmann DR; Yu L; Wang TB; Eisenbarth GS
    Diabetologia; 1997 Mar; 40(3):332-8. PubMed ID: 9084973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart.
    Schloot NC; Willemen SJ; Duinkerken G; Drijfhout JW; de Vries RR; Roep BO
    Hum Immunol; 2001 Apr; 62(4):299-309. PubMed ID: 11295462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell responses to type 1 diabetes related peptides sharing homologous regions.
    Sarugeri E; Dozio N; Meschi F; Pastore MR; Bonifacio E
    J Mol Med (Berl); 2001 May; 79(4):213-20. PubMed ID: 11409713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two amino acids in glutamic acid decarboxylase act in concert for maintenance of conformational determinants recognised by Type I diabetic autoantibodies.
    Tree TI; Morgenthaler NG; Duhindan N; Hicks KE; Madec AM; Scherbaum WA; Banga JP
    Diabetologia; 2000 Jul; 43(7):881-9. PubMed ID: 10952461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.